Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Free guided tours at the Connecticut College Arboretum begin in May. Tours start at 10 a.m. on the first and second Sunday of each month from May thru October. Our free guided tours are open to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback